Metabolism - Clinical and Experimental
Volume 47, Issue 5 , Pages 497-502, May 1998

Hyperglucagonemia and the immediate fate of dietary leucine: A kinetic study in humans

  • J.Sergio Marchini

      Affiliations

    • Centre de Recherche en Nutrition Humaine, Groupe Métabolisme, Université de Nantes, Nantes, France
    • Division of Clinical Nutrition, School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
    • Laboratory of Human Nutrition and Clinical Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA
  • ,
  • Lisa M. Marks

      Affiliations

    • Centre de Recherche en Nutrition Humaine, Groupe Métabolisme, Université de Nantes, Nantes, France
    • Division of Clinical Nutrition, School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
    • Laboratory of Human Nutrition and Clinical Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA
  • ,
  • Dominique Darmaun

      Affiliations

    • Centre de Recherche en Nutrition Humaine, Groupe Métabolisme, Université de Nantes, Nantes, France
    • Division of Clinical Nutrition, School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
    • Laboratory of Human Nutrition and Clinical Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA
  • ,
  • Vernon R. Young

      Affiliations

    • Centre de Recherche en Nutrition Humaine, Groupe Métabolisme, Université de Nantes, Nantes, France
    • Division of Clinical Nutrition, School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
    • Laboratory of Human Nutrition and Clinical Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA
  • ,
  • Michel Krempf

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Michel Krempf, MD, Clinique d'Endocrinologie, Maladies Métaboliques et Nutrition, Hôtel Dieu, 44093 Nantes cedex 1, France.
    • Centre de Recherche en Nutrition Humaine, Groupe Métabolisme, Université de Nantes, Nantes, France
    • Division of Clinical Nutrition, School of Medicine of Ribeirao Preto, Ribeirao Preto, Brazil
    • Laboratory of Human Nutrition and Clinical Research Center, Massachusetts Institute of Technology, Cambridge, MA, USA

Received 23 January 1997; accepted 8 August 1997.

Abstract 

The possible role of glucagon in determining the fate of dietary absorbed amino acids within the splanchnic bed was investigated in five healthy male volunteers. A kinetic study was performed involving a continuous 240-minute infusion of l-[5,5,5-2H3]leucine and d-[6,6-2H2]glucose by vein, while l-[1-13C]leucine was infused by a feeding tube into the duodenum (intragut [IG]) along with a constant intravenous (IV) infusion of somatotropin release-inhibitory factor (SRIF) combined with insulin, growth hormone, and glucagon. In random order, glucagon was infused at a rate of 0.4 ng · kg−1 · min−1 in one experiment and 1.2 ng · kg−1 · min−1 in the other experiment, while insulin and growth hormone were kept at constant serum levels, respectively, 37 ± 13 pmol · L−1 and 5 ± 0.2 μg · L−1. The diet was provided as an l-amino acid solution including 60 μmol · kg−1 · h−1 leucine without fat and carbohydrate. During the higher rate of glucagon infusion, there was an increase in plasma glucagon and glucose concentrations, glucose flux, and net dietary leucine release into the periphery from the splanchnic bed. Splanchnic removal and uptake of leucine were decreased with increased glucagon infusion. There were no statistical differences in the plasma leucine level and IV and IG leucine fluxes at the two glucagon levels, although leucine metabolic clearance increased (0.74 v 0.85 L · kg−1 · h−1, P = .08) in the case of glucagon excess. Plasma glucose increased with glucagon excess and was negatively correlated (P < .05) with the plasma leucine level (r = −.348) and IV (r = −.459) or I.G. (r = −.359) leucine fluxes. The negative correlation between plasma glucagon and leucine levels was also significant (r = −.684). No significant correlation was found between dietary leucine splanchnic removal and glucose, glucagon, or leucine plasma concentrations. We conclude that glucagon in excess has only a small quantitative effect on the overall handling of dietary leucine, and hypothesize that more leucine is exported to the peripheral tissues under these hormonal conditions.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported by Nantes University, National Institutes of Health Grant No. DK15856 (V.R.Y.), and FAPESP-BR 95/9776-1 (J.S.M.).

PII: S0026-0495(98)90230-X

Metabolism - Clinical and Experimental
Volume 47, Issue 5 , Pages 497-502, May 1998